| RS2548297262 |
CAPN3
|
Health Risk |
Likely pathogenic |
Muscular dystrophy, limb-girdle |
| RS2548298268 |
PRPH2
|
Health Risk |
Pathogenic |
PRPH2-related disorder, PRPH2-related disorder |
| RS2548298274 |
PRPH2
|
Health Risk |
Pathogenic |
PRPH2-related disorder, PRPH2-related disorder |
| RS2548298312 |
PRPH2
|
Health Risk |
Pathogenic |
PRPH2-related disorder, PRPH2-related disorder |
| RS2548298343 |
PRPH2
|
Health Risk |
Likely pathogenic |
Patterned dystrophy of the retinal pigment epithelium, Patterned dystrophy of the retinal pigment epithelium |
| RS2548298363 |
PRPH2
|
Health Risk |
Pathogenic |
PRPH2-related disorder, PRPH2-related disorder |
| RS2548298397 |
PRPH2
|
Health Risk |
Pathogenic |
PRPH2-related disorder, PRPH2-related disorder |
| RS2548299083 |
TRAP1
|
Health Risk |
Pathogenic |
Congenital anomalies of kidney and urinary tract 1, Congenital anomalies of kidney and urinary tract 1 |
| RS2548300655 |
PRPH2
|
Health Risk |
Pathogenic |
PRPH2-related disorder, PRPH2-related disorder |
| RS2548300670 |
PRPH2
|
Health Risk |
Pathogenic |
PRPH2-related disorder, PRPH2-related disorder |
| RS2548300686 |
PRPH2
|
Health Risk |
Pathogenic |
PRPH2-related disorder, PRPH2-related disorder |
| RS2548300727 |
PRPH2
|
Health Risk |
Pathogenic |
PRPH2-related disorder, PRPH2-related disorder |
| RS2548300729 |
PRPH2
|
Health Risk |
Pathogenic |
PRPH2-related disorder, PRPH2-related disorder |
| RS2548300768 |
PRPH2
|
Health Risk |
Likely pathogenic |
PRPH2-related disorder, PRPH2-related disorder |
| RS2548300782 |
PRPH2
|
Health Risk |
Pathogenic |
PRPH2-related disorder, PRPH2-related disorder |
| RS2548300805 |
PRPH2
|
Health Risk |
Likely pathogenic |
Retinal dystrophy, Retinal dystrophy |
| RS2548300822 |
PRPH2
|
Health Risk |
Pathogenic |
PRPH2-related disorder, PRPH2-related disorder |
| RS2548300838 |
PRPH2
|
Health Risk |
Pathogenic |
PRPH2-related disorder, PRPH2-related disorder |
| RS2548303507 |
TPK1
|
Health Risk |
Likely pathogenic |
Childhood encephalopathy due to thiamine pyrophosphokinase deficiency, Childhood encephalopathy due to thiamine pyrophosphokinase deficiency |
| RS2548303949 |
TPK1
|
Health Risk |
Pathogenic |
Childhood encephalopathy due to thiamine pyrophosphokinase deficiency, Childhood encephalopathy due to thiamine pyrophosphokinase deficiency |
| RS2548305568 |
RPS17
|
Health Risk |
Likely pathogenic |
Diamond-Blackfan anemia 4, Diamond-Blackfan anemia 4 |
| RS2548306210 |
PCCA
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2548306430 |
RPS17
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia |
| RS2548306778 |
RPS17
|
Health Risk |
Pathogenic/Likely pathogenic |
Diamond-Blackfan anemia, Diamond-Blackfan anemia 4 |
| RS2548309582 |
PRPH2
|
Health Risk |
Pathogenic |
PRPH2-related disorder, PRPH2-related disorder |
| RS2548309605 |
PRPH2
|
Health Risk |
Pathogenic |
PRPH2-related disorder, PRPH2-related disorder |
| RS2548309643 |
PRPH2
|
Health Risk |
Likely pathogenic |
PRPH2-related disorder, PRPH2-related disorder |
| RS2548309652 |
PRPH2
|
Health Risk |
Likely pathogenic |
PRPH2-related disorder, PRPH2-related disorder |
| RS2548309660 |
PRPH2
|
Health Risk |
Pathogenic |
PRPH2-related disorder, PRPH2-related disorder |
| RS2548309705 |
PRPH2
|
Health Risk |
Pathogenic |
PRPH2-related disorder, PRPH2-related disorder |
| RS2548309708 |
PRPH2
|
Health Risk |
Pathogenic |
PRPH2-related disorder, PRPH2-related disorder |
| RS2548309755 |
PRPH2
|
Health Risk |
Pathogenic |
PRPH2-related disorder, PRPH2-related disorder |
| RS2548309785 |
PRPH2
|
Health Risk |
Pathogenic |
PRPH2-related disorder, PRPH2-related disorder |
| RS2548309835 |
PRPH2
|
Health Risk |
Pathogenic |
PRPH2-related disorder, PRPH2-related disorder |
| RS2548309917 |
PRPH2
|
Health Risk |
Pathogenic |
PRPH2-related disorder, PRPH2-related disorder |
| RS2548309957 |
PRPH2
|
Health Risk |
Pathogenic |
PRPH2-related disorder, PRPH2-related disorder |
| RS2548311523 |
NTHL1
|
Health Risk |
Likely pathogenic |
Familial adenomatous polyposis 3, Familial adenomatous polyposis 3 |
| RS2548311703 |
NTHL1
|
Health Risk |
Likely pathogenic |
Familial adenomatous polyposis 3, Familial adenomatous polyposis 3 |
| RS2548311864 |
NTHL1
|
Health Risk |
Likely pathogenic |
Familial adenomatous polyposis 3, Familial adenomatous polyposis 3 |
| RS2548311907 |
NTHL1
|
Health Risk |
Pathogenic |
— |
| RS2548311973 |
NTHL1
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 3, Familial adenomatous polyposis 3 |
| RS2548311981 |
NTHL1
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 3, Familial adenomatous polyposis 3 |
| RS2548312011 |
NTHL1
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 3, Familial adenomatous polyposis 3 |
| RS2548312102 |
NTHL1
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 3, Familial adenomatous polyposis 3 |
| RS2548314985 |
NTHL1
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 3, Hereditary cancer-predisposing syndrome |
| RS2548314993 |
NTHL1
|
Health Risk |
Pathogenic |
— |
| RS2548315004 |
NTHL1
|
Health Risk |
Pathogenic |
— |
| RS2548315043 |
NTHL1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2548315071 |
NTHL1
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 3, Familial adenomatous polyposis 3 |
| RS2548315153 |
NTHL1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2548315177 |
NTHL1
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 3, Familial adenomatous polyposis 3 |
| RS2548315183 |
NTHL1
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 3, Familial adenomatous polyposis 3 |
| RS2548315200 |
NTHL1
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 3, Hereditary cancer-predisposing syndrome |
| RS2548315238 |
NTHL1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 1 |
| RS2548315247 |
NTHL1
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 3, Hereditary cancer-predisposing syndrome |
| RS2548315270 |
NTHL1
|
Health Risk |
Likely pathogenic |
Familial adenomatous polyposis 3, Familial adenomatous polyposis 3 |
| RS2548316205 |
NTHL1
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 3, Familial adenomatous polyposis 3 |
| RS2548316221 |
NTHL1
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 3, Familial adenomatous polyposis 3 |
| RS2548316235 |
NTHL1
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 3, Familial adenomatous polyposis 3 |
| RS2548316266 |
NTHL1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2548316271 |
NTHL1
|
Health Risk |
Likely pathogenic |
— |
| RS2548316296 |
NTHL1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2548316318 |
NTHL1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 3 |
| RS2548316384 |
NTHL1
|
Health Risk |
Likely pathogenic |
Familial adenomatous polyposis 3, Familial adenomatous polyposis 3 |
| RS2548316432 |
NTHL1
|
Health Risk |
Pathogenic |
— |
| RS2548316459 |
NTHL1
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 3, Hereditary cancer-predisposing syndrome |
| RS2548316461 |
NTHL1
|
Health Risk |
Pathogenic |
— |
| RS2548319061 |
NTHL1
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 3, Familial adenomatous polyposis 3 |
| RS2548319118 |
NTHL1
|
Health Risk |
Pathogenic |
— |
| RS2548319297 |
NTHL1
|
Health Risk |
Pathogenic |
— |
| RS2548319413 |
NTHL1
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 3, Familial adenomatous polyposis 3 |
| RS2548319666 |
NTHL1
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 3, Familial adenomatous polyposis 3 |
| RS2548319715 |
NTHL1
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 3, Familial adenomatous polyposis 3 |
| RS2548320418 |
NTHL1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 3 |
| RS2548320449 |
NTHL1
|
Health Risk |
Pathogenic |
— |
| RS2548320617 |
NTHL1
|
Health Risk |
Pathogenic |
— |
| RS2548320697 |
NTHL1
|
Health Risk |
Pathogenic |
— |
| RS2548320872 |
NTHL1
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial adenomatous polyposis 3, Familial adenomatous polyposis 3 |
| RS2548321081 |
NTHL1
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 3, Familial adenomatous polyposis 3 |
| RS2548321272 |
NTHL1
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 3, Familial adenomatous polyposis 3 |
| RS2548321541 |
NTHL1
|
Health Risk |
Pathogenic |
— |
| RS2548321575 |
NTHL1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 3 |
| RS2548325639 |
ADAMTS17
|
Health Risk |
Pathogenic |
— |
| RS2548329655 |
CYP11A1
|
Health Risk |
Pathogenic |
— |
| RS2548330553 |
CYP11A1
|
Health Risk |
Pathogenic |
— |
| RS2548330915 |
CYP11A1
|
Health Risk |
Pathogenic |
— |
| RS2548330928 |
CYP11A1
|
Health Risk |
Pathogenic |
— |
| RS2548330961 |
CYP11A1
|
Health Risk |
Pathogenic |
Congenital adrenal insufficiency with 46, XY sex reversal OR 46 |
| RS2548331284 |
NTHL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2548331710 |
NTHL1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2548331721 |
NTHL1
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 3, Familial adenomatous polyposis 3 |
| RS2548331747 |
NTHL1
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 3, Familial adenomatous polyposis 3 |
| RS2548331798 |
NTHL1
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 3, Familial adenomatous polyposis 3 |
| RS2548331844 |
NTHL1
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 3, Hereditary cancer-predisposing syndrome |
| RS2548331894 |
NTHL1
|
Health Risk |
Likely pathogenic |
Familial adenomatous polyposis 3, Familial adenomatous polyposis 3 |
| RS2548331971 |
NTHL1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2548332224 |
NTHL1
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 3, Familial adenomatous polyposis 3 |
| RS2548332320 |
NTHL1
|
Health Risk |
Pathogenic |
— |
| RS2548332680 |
KAT6B
|
Health Risk |
Likely pathogenic |
Blepharophimosis - intellectual disability syndrome, SBBYS type |
| RS2548333540 |
KAT6B
|
Health Risk |
Likely pathogenic |
Blepharophimosis - intellectual disability syndrome, SBBYS type |